| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/01/2002 | US20020103345 Bispecific immunoglobulin-like antigen binding proteins and method of production |
| 08/01/2002 | US20020103344 Glycoprotein mutants of retrovirus envelopes and their biological applications |
| 08/01/2002 | US20020103342 Polypeptide for use in the diagnosis, prevention, and treatment of developmental, reproductive, immunological, and tumor disorders |
| 08/01/2002 | US20020103341 Annexin derivatives with endogenous chelation sites |
| 08/01/2002 | US20020103340 Rab proteins |
| 08/01/2002 | US20020103339 Polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and immune disorders |
| 08/01/2002 | US20020103338 Staphylococcus aureus polynucleotides and polypeptides |
| 08/01/2002 | US20020103336 Cloning of chicken anemia dna |
| 08/01/2002 | US20020103335 Peptide derivatives |
| 08/01/2002 | US20020103334 Aprotinin variants having a net charge of +3 to -3 at pH 7 and with the amino acids Arg15 or Arg15-Ala17 in the binding region; serine protease inhibitor |
| 08/01/2002 | US20020103263 Method of using lectins for contraception,prophylaxis against diseases transmittable by sexual contact, and therapy of such diseases, and apparatus for administering lectins |
| 08/01/2002 | US20020103221 Such as 2-amino-N-(2-(3a-(R)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro-pyrazolo -(4,3-c)pyridin-5-yl)-1-(R)-benzyloxymethyl- 2-oxo-ethyl)-isobutyramide or prodrug thereof; for improving functional health of elderly/isolated |
| 08/01/2002 | US20020103190 Azo amino acids derivatives |
| 08/01/2002 | US20020103184 Cyclic malonamides as inhibitors of a beta protein production |
| 08/01/2002 | US20020103183 Insulin receptor kinase activators; treating hyperglycemia; 4-((3,5-bis(N-(4-sulfophenyl)carbamoyl)phenyl)carbonylamino)-benzenesulfonic acid, for example |
| 08/01/2002 | US20020103153 Antiproliferative and anticarcinogenic agents; gene therapy |
| 08/01/2002 | US20020103151 Methods and compositions for immunomodulation |
| 08/01/2002 | US20020103150 Screening for compounds that affect uncoupling by contacting a cell or tissue sample with a candidate compound and analyzing the expression of human OGC; treating metabolic disorders, e.g. cachexcia; gene therapy |
| 08/01/2002 | US20020103149 An isolated nucleic acid molecule encoding a novel varient of vascular endothelial growth factor; vectors and host cells and reactive antibodies; controlling neovascularization; antitumor, - carcinogenic agents |
| 08/01/2002 | US20020103147 Enhancing cardiac function in a mammal by delivering to the heart a vector comprising a gene encoding a beta-adrenergic signaling protein (beta-ASP) operably linked to a promoter; using a recombinant viral vector replication-defective |
| 08/01/2002 | US20020103146 An antisense oligonucleotide encoding the title protein specifically hybridizes with and inhibits the expression of the title protein; antiproliferative, -carcinogenic agents; viricides; hepatitis |
| 08/01/2002 | US20020103143 Use of nucleic acid molecules as antiviral agents |
| 08/01/2002 | US20020103138 Modulating the immune system for more efficient immune response to malignant cells |
| 08/01/2002 | US20020103136 Conjugates useful in the treatment of prostate cancer |
| 08/01/2002 | US20020103135 Modulating the activity of serine proteases |
| 08/01/2002 | US20020103134 Modulators of beta-amyloid peptide aggregation comprising D-amino acids |
| 08/01/2002 | US20020103133 Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use |
| 08/01/2002 | US20020103132 Administering a neuropeptide of bombesin, gastrin-releasing polypeptide, a neuropeptide having an amino acid C terminus corresponding to Trp-Ala-Val-Gly-His-Leu-Met-NH2 |
| 08/01/2002 | US20020103131 Prevention of diabetes by administration of GnRH antagonists |
| 08/01/2002 | US20020103130 Amino acid sequence RX1ETX2WX3 (SEQ ID NO: ) wherein X1, X2 and X3 are any amino acid |
| 08/01/2002 | US20020103129 Small peptides having anti-angiogenic and endothelial cell inhibition activity |
| 08/01/2002 | US20020103128 Infecting a cell with infectious pancreatic necrosis virus |
| 08/01/2002 | US20020103127 Inhibitors of proteasomal activity for stimulating hair growth |
| 08/01/2002 | US20020103126 Stable pharmaceutical form of administration for peptides, proteins and nucleic acids |
| 08/01/2002 | US20020103125 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/01/2002 | US20020103124 Administering a peptide having the sequence Tyr-D-Leu-Phe-Ala-Asp-Val-Ala-Ser-Thr-Ile-Gly-Asp-Phe-Phe-His-Ser-Ile-NH2 |
| 08/01/2002 | US20020103123 Administering coumpounds such as aromatic alkyl diamine derivatives as Y5 receptor agonist or antagonist to increase or decrease food consumption |
| 08/01/2002 | US20020103122 Methods of treatment and prevention of restenosis |
| 08/01/2002 | US20020103121 Amino acid sequence of residues 163-199 used to induce apoptosis in a cell |
| 08/01/2002 | US20020103120 Regulation of human phosphodiesterase-like enzyme |
| 08/01/2002 | US20020103118 For treatment of diseases such as tuberculosis and leprosy; may be administered along with antibiotic |
| 08/01/2002 | US20020103117 For reduction in blood pressure, prevention and/or treatment of diseases in which a beta-antagonist can be used |
| 08/01/2002 | US20020103116 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/01/2002 | US20020103115 Useful in the development of human therapeutics and diagnostic compositions and methods |
| 08/01/2002 | US20020103114 Administering therapeutically effective amount of bactericidal/permeability-increasing protein product to a human suffering from meningococcemia |
| 08/01/2002 | US20020103113 Oligopeptide lyophilisate, their preparation and use |
| 08/01/2002 | US20020103112 Wound healing and treatment of fibrosis |
| 08/01/2002 | US20020103111 Comprising peptide sequences which mimic the conserved amino acid motif LDTSL of MAdCAM-1 and which have groups bonded to the N- and C- termini; treatment of inflammatory bowel disease |
| 08/01/2002 | US20020103106 Methods of inducing ovulation |
| 08/01/2002 | US20020103104 Administering to individual a antibacterially effective amount of an antagonist that inhibits or an agonist that activates an activity of a signal recognition particle polypeptide |
| 08/01/2002 | US20020102733 Drug delivery system; obtain receptive binding particles, incubate with surface and hydrophilic polymer, incubate with release agent, monitor distribution through biological systems |
| 08/01/2002 | US20020102730 Expression system for factor VIII |
| 08/01/2002 | US20020102729 Formulations for electroporation |
| 08/01/2002 | US20020102724 Novel hematopoietic genes and polypeptides |
| 08/01/2002 | US20020102723 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of pancreatic defects |
| 08/01/2002 | US20020102712 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of viral diseases |
| 08/01/2002 | US20020102711 Polypeptide for use in the treatment of cancer and immunological |
| 08/01/2002 | US20020102710 Polypeptide for use in the treatment of cancer, autoimmune diseases and inflammation |
| 08/01/2002 | US20020102708 SH3-containing proteins |
| 08/01/2002 | US20020102707 Nucleotide sequences coding polypeptide for use in the treatment of sexual disorders |
| 08/01/2002 | US20020102703 Kunitz domain polypeptide zkun10 |
| 08/01/2002 | US20020102701 licD1 |
| 08/01/2002 | US20020102700 metK |
| 08/01/2002 | US20020102694 Nucleozymes with endonuclease activity |
| 08/01/2002 | US20020102691 Enzymatic polypeptide for use in treatment and prevention of, heart liver and inflammatory disorders |
| 08/01/2002 | US20020102686 Inactive variants of the human telomerase catalytic subunit |
| 08/01/2002 | US20020102684 Human phospholipase inhibitor |
| 08/01/2002 | US20020102683 Nucleotide sequences coding enzymatic polypeptide for use in human therapeutics, cosmetics, nutrients and pharmacology |
| 08/01/2002 | US20020102676 Nucleotide sequences coding membrane proteins for use in cancer therapy |
| 08/01/2002 | US20020102666 PSCA: prostate stem cell antigen and uses thereof |
| 08/01/2002 | US20020102658 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 08/01/2002 | US20020102657 Binding protein for use as therapeutic tool in the prevention of Infections disease |
| 08/01/2002 | US20020102654 Thioredoxin proteins |
| 08/01/2002 | US20020102653 DNA coding for human cell surface antigen |
| 08/01/2002 | US20020102652 Polypeptide for use in the diagnosis, prevention and treatment of tumors and autoimmune diseases |
| 08/01/2002 | US20020102651 Novel B7-4 molecules and uses therefor |
| 08/01/2002 | US20020102649 Human transport protein homologs |
| 08/01/2002 | US20020102647 Nucleotide sequences coding membrane protein for use in treatment of nervous system disorders and arthritis |
| 08/01/2002 | US20020102644 Pharmaceutical compositions comprising herpes virus entry receptor protein |
| 08/01/2002 | US20020102643 Dorsal tissue affecting factor and compositions |
| 08/01/2002 | US20020102642 Nuclelotide sequences coding preferential protein for use in therapeutic, diagnostic and medical imaging |
| 08/01/2002 | US20020102641 Oncogenic osteomalacia-related gene 1 |
| 08/01/2002 | US20020102640 Nucleotide sequences coding preferential protein for use in the diagnosis, prevention and treatment of cancer |
| 08/01/2002 | US20020102637 Peptides for use in human therapeutics and diagnostics associated with pancreatic defects |
| 08/01/2002 | US20020102633 Polypeptide for use in the treatment bone disorders and osteoarthritis |
| 08/01/2002 | US20020102622 Cardiotrophin-1 compositions and methods for the treatment of tumor |
| 08/01/2002 | US20020102621 Kit for use in diagnosis and treatment of tumors |
| 08/01/2002 | US20020102619 Heparanase specific molecular probes and their use in research and medical applications |
| 08/01/2002 | US20020102616 Islet cell antigen 1851 |
| 08/01/2002 | US20020102609 Antagonists of HMG1 for treating inflammatory conditions |
| 08/01/2002 | US20020102603 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 08/01/2002 | US20020102602 Polypeptide for use as an antitumor agent |
| 08/01/2002 | US20020102588 Human MutT2 |
| 08/01/2002 | US20020102585 Prostate growth-associated membrane proteins |
| 08/01/2002 | US20020102581 Diagnostics and therapeutics for ocular disorders |
| 08/01/2002 | US20020102573 Monitoring, detecting, screening and determining pancreatic defects in humans; obtain and determine nucleotide sequence of sample, compare to control, detect mutation, evaluate human for pancreatic defects |
| 08/01/2002 | US20020102569 Nucleotide sequences for use in the detection, classificataions, treatment and evaluation of cancer therapies |
| 08/01/2002 | US20020102568 Nucleic acid sensor molecules |
| 08/01/2002 | US20020102560 Nucleotide sequences coding enzymatic polypeptide for use in treatment metastasis and tumors |
| 08/01/2002 | US20020102552 Nucleotide sequences coding preferential polypeptide for use in the treatment of diabetes and eating disorders |